Combination of treating and/or preventing hemorrhoid
A kind of composition, the technology of medicine, be used in the field of combination therapy for the treatment of hemorrhoids, and the field of pharmaceutical compositions for the treatment and/or prevention of hemorrhoids
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0093] Example 1: Differences in MVD and elastic fibers between hemorrhoid tissue and relatively normal anal cushion tissue, as well as the expression and difference of NOS, PDE5, VEGF, MMP1, 3, 9, and 12
[0094] 1. Materials and methods
[0095] Selected 24 cases of suprahemorrhoidal mucosal circumcision and stapling (PPH surgery) specimens obtained from October 2003 to August 2004, mainly selecting one or two female hemorrhoids among the three female hemorrhoids with obvious lesions, but at least one female hemorrhoid Internal hemorrhoid specimens from patients with grade III hemorrhoids with inconspicuous "hemorrhoids" lesions. The patients were aged between 35-60. After PPH operation, the protruding female hemorrhoid tissue and relatively normal anal cushion tissue were fixed in 15% neutral formalin solution, embedded in paraffin, and serially sectioned.
[0096] Paraffin sections of all patients were stained by H.E and immunohistochemical streptavidin-biophilin-peroxid...
Embodiment 2
[0116] Example 2: Preparation of Suppository A Containing At Least One Nitric Oxide Synthase Inhibitor At Least One Angiogenesis Inhibitor And At Least One Matrix Metalloproteinase Inhibitor
[0117] With conventional suppository preparation method, the following compounds are mixed in the content ratio described in the table (table 2):
[0118]
ingredient name
in each suppository
content of ingredients
Features
activity
Element
Aminoguanidine
10mg
NOS inhibitor
10mg
VEGF inhibitor
1mg
MMP inhibitor
That
he
become
Minute
Polyoxyethylene glycol palmitate
Fatty acid ester
160mg
Self-emulsifying fat base
Saturated Polysaccharide Glycerides
120mg
fat soluble carrier
Dimethicone
320mg
liquid solvent
Hydrophobic hydroxypropyl methylcellulose
...
Embodiment 3
[0121] Example 3: Preparation of Suppository B Containing At Least One Nitric Oxide Synthase Inhibitor At Least One Angiogenesis Inhibitor And At Least One Matrix Metalloproteinase Inhibitor
[0122] With conventional suppository preparation method, the following compounds are mixed according to the content ratio described in the table (table 3):
[0123]
ingredient name
in each suppository
content of ingredients
Features
live
sex
become
Minute
COL-3
10mg
MMP inhibitor
N-monomethyl-L-arginine
sour
10mg
NOS inhibitor
10mg
VEGF inhibitors
That
he
become
Minute
Polyoxyethylene glycol palmitate
Fatty acid ester
160mg
Self-emulsifying fat base
Saturated Polysaccharide Glycerides
120mg
fat soluble carrier
Dimethicone
320mg
liquid...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com